Award
University of Utah UU95848140-3
External Next Gen Sequencing Runs Stage 3
Recipient
Fulgent Therapeutics, LLC; Genomics and Microarray Core Facility (University of Colorado)
Awarded
March 30, 2018
Identifier
UU95848140-3
The University of Utah awarded the External Next Gen Sequencing Runs Stage 3 solicitation to Fulgent Therapeutics, LLC and the University of Colorado Genomics and Microarray Core Facility. No award amount is stated.
Description
Multiple award for external next-generation sequencing runs. The award document identifies Fulgent Therapeutics, LLC and the Genomics and Microarray Core Facility (University of Colorado) as awardees.